|
DE102016114392A1
|
|
A compound for the treatment of a disease associated with a desegregation of the alternative complement pathway
|
|
DE102016113441A1
|
|
Substance for the treatment of nephrotic syndrome
|
|
DE102016105069A1
|
|
Antiviral immunotherapy by membrane receptor ligation
|
|
DE102016103560A1
|
|
System for use in organ replacement or support procedures
|
|
DE102015119873A1
|
|
New tumor marker for rhabdomyosarcoma
|
|
DE102015115877A1
|
|
Prophylaxis and treatment of cystic fibrosis
|
|
DE102015115876A1
|
|
Substance for the prophylaxis and treatment of infections caused by influenza viruses
|
|
DE102015114483A1
|
|
Coil arrangement and system for transcranial magnetic stimulation
|
|
DE102015114538A1
|
|
Multi-lumen catheter for performing endoscopic interventions
|
|
DE102015111756A1
|
|
Recombinant Orf virus vector
|
|
DE102015110605B3
|
|
Method and apparatus for detecting blood vessel types of retinal blood vessels, and computer readable medium with instructions
|
|
EP3157427A1
|
|
Method and device for examining the faculty of hearing
|
|
DE102015108523A1
|
|
Peptide biomarker for cancer
|
|
DE102015106731A1
|
|
Peptides for cancer immunotherapy
|
|
DE102015101273A1
|
|
Prophylaxis and treatment of premature birth-related developmental disorders
|
|
DE102014117532A1
|
|
Antimicrobial photodynamic therapy
|
|
DE102014116334A1
|
|
Production of Recombinant Expression Vectors
|
|
DE102014112747A1
|
|
Use of a quinoxaline derivative in an imaging process
|
|
DE102014111892A1
|
|
Prophylaxis and treatment of hantavirus infection
|
|
DE102014110783A1
|
|
Composition for modulating the activity of non-structural proteins
|
